Literature DB >> 3089742

Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.

K Sasaki, T Murakami, T Ogino, M Takahashi, S Kawasaki.   

Abstract

An estimation of cell kinetic parameters was made by simultaneous flow cytometric measurements of DNA and bromodeoxyuridine (BrdUrd) contents of cells. The procedure described in this paper involves the incorporation of BrdUrd by S phase cells, labeling the BrdUrd with an indirect immunofluorescent technique using a monoclonal anti-BrdUrd antibody, and staining DNA with propidium iodide (PI). The amount of incorporated BrdUrd in HeLa cells was proportional to that of synthesized DNA through S phase. For all cell lines examined, the pattern of BrdUrd incorporation was essentially the same and the rate of DNA synthesis during S phase was not constant. The bivariate BrdUrd/DNA distributions showed a horse-shoe pattern, maximum in the mid S phase and minimum in the early and late S phases. Furthermore, the durations of cell cycle (Tc) and S phase (Ts) were estimated from a FLSm (fraction of labeled cells in mid S phase) curve that was generated by plotting the percentage of BrdUrd pulse-labeled cells in a narrow window defined in the mid S phase of the DNA histogram. The values of these parameters in NIH 3T3, HeLa S3, and HL-60 cells were in good accordance with the reported data. This FCM method using the monoclonal anti-BrdUrd antibody allows rapid determination of both cell cycle compartments and also Ts and Tc without the use of radioactive DNA precursors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089742     DOI: 10.1002/cyto.990070415

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  9 in total

1.  SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.

Authors:  Alejandro Vaquero; Michael B Scher; Dong Hoon Lee; Ann Sutton; Hwei-Ling Cheng; Frederick W Alt; Lourdes Serrano; Rolf Sternglanz; Danny Reinberg
Journal:  Genes Dev       Date:  2006-04-28       Impact factor: 11.361

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

3.  Flow cytometric method to detect lymphocyte transformation in drug-allergic hepatic injury.

Authors:  T Ikeda; O Noguchi; F Kobayashi; S Tozuka; K Tokushima; S Sakamoto; F Marumo; C Sato
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.487

4.  A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.

Authors:  B Nakata; Y S Chung; M Sowa
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

6.  Effect of hyperthermia on cyclin B expression in a human glioblastoma cell line.

Authors:  N Ohshita; T Nishizaki; H Ishihara; H Ito; T Murakami; Y Mimura
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.

Authors:  S Genka; N Shitara; Y Tsujita; Y Kosugi; K Takakura
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

8.  Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.

Authors:  A Marcuzzi; B Van Ness; T Rouse; D Lafrenz
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

9.  Energetics of nutrition and polyamine-related tumor growth alterations in experimental cancer.

Authors:  T Westin; B Soussi; J P Idström; P Lindnér; S Edström; E Lydén; B Gustavsson; L Hafström; K Lundholm
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.